Vitrolife AB (OSTO:VITR) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


OSTO:VITR Vitrolife AB OSTO:VITR
78 GF Score
Price kr89.65
GF Value kr162.15
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vitrolife AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

OSTO:VITR vs ABT, SYK, MDT: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Vitrolife AB's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitrolife AB Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Margin of Safety % (DCF Earnings Based) falls into.


OSTO:VITR
78GF Score
Vitrolife AB OSTO:VITR
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vitrolife AB (OSTO:VITR) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr89.65 is trading 44.7% below its estimated GF Value™ of kr162.15. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for OSTO:VITR:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: kr162.15 vs. price of kr89.65 (44.7% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the OSTO:VITR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
78GF Score

Get the complete analysis for OSTO:VITR

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr89.65
Price
kr162.15
GF Value